FocusCancer Immunotherapy

Targeting TNFR2, an immune checkpoint stimulator and oncoprotein, is a promising treatment for cancer

See allHide authors and affiliations

Science Signaling  17 Jan 2017:
Vol. 10, Issue 462, eaal2328
DOI: 10.1126/scisignal.aal2328

Log in to view Figures & Data

Log in through your institution

Log in through your institution

Stay Connected to Science Signaling